» Articles » PMID: 21961714

Adrenal Androgens and the Menopausal Transition

Overview
Date 2011 Oct 4
PMID 21961714
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The concept that adrenal androgen production gradually declines with age has changed after analysis of longitudinal data from the Study of Women's Health Across the Nation (SWAN). It is now recognized that 4 adrenal androgens rise during the menopausal transition in most women. Ethnic and individual differences in sex steroids are more apparent in circulating adrenal steroids than in either estradiol or cyclic ovarian steroid hormone profiles, particularly during the early and late perimenopause. Thus, adrenal steroid production may play a larger role in the occurrence of symptoms and the potential for healthier aging than previously recognized.

Citing Articles

DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers.

Hugh J, Haddon L, Githaka J Biomedicines. 2024; 12(6).

PMID: 38927507 PMC: 11201522. DOI: 10.3390/biomedicines12061300.


PPI-Induced Changes in Plasma Metabolite Levels Influence Total Hip Bone Mineral Density in a UK Cohort.

Zhang X, Adebayo A, Wang D, Raza Y, Tomlinson M, Dooley H J Bone Miner Res. 2022; 38(2):326-334.

PMID: 36458982 PMC: 10108201. DOI: 10.1002/jbmr.4754.


Sex steroids and sex steroid-binding globulin levels amongst middle-aged and elderly men and women from general population.

Aribas E, Roeters van Lennep J, de Rijke Y, Laven J, Ikram M, Peeters R Eur J Clin Invest. 2022; 52(12):e13866.

PMID: 36038500 PMC: 9787498. DOI: 10.1111/eci.13866.


Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers.

Bleach R, Sherlock M, OReilly M, McIlroy M Front Cell Dev Biol. 2021; 9:630503.

PMID: 33816477 PMC: 8012538. DOI: 10.3389/fcell.2021.630503.


Is menopause still evolving? Evidence from a longitudinal study of multiethnic populations and its relevance to women's health.

Chan S, Gomes A, Singh R BMC Womens Health. 2020; 20(1):74.

PMID: 32307019 PMC: 7168978. DOI: 10.1186/s12905-020-00932-8.


References
1.
Longcope C, Franz C, Morello C, Baker R, JOHNSTON Jr C . Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 1986; 8(3):189-96. DOI: 10.1016/0378-5122(86)90025-3. View

2.
Traish A, Huang Y, Min K, Kim N, Munarriz R, Goldstein I . Binding characteristics of [3H]delta(5)-androstene-3beta,17beta-diol to a nuclear protein in the rabbit vagina. Steroids. 2004; 69(1):71-8. DOI: 10.1016/j.steroids.2003.10.006. View

3.
Adams J . Estrogenic effects of 5-androstene-3 beta, 17 beta-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology. 1983; 112(2):486-91. DOI: 10.1210/endo-112-2-486. View

4.
Santoro N, Brown J, Adel T, Skurnick J . Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996; 81(4):1495-501. DOI: 10.1210/jcem.81.4.8636357. View

5.
Janssen I, Powell L, Crawford S, Lasley B, Sutton-Tyrrell K . Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med. 2008; 168(14):1568-75. PMC: 2894539. DOI: 10.1001/archinte.168.14.1568. View